Cyclic Guanosine Monophosphate (cGMP)-Dependent Protein Kinase II Blocks Epidermal Growth Factor (EGF)/Epidermal Growth Factor Receptor (EGFR)-Induced Biological Effects on Osteosarcoma Cells

Documenti analoghi

• Inhibition of PDE5A1 guanosine cyclic monophosphate (cGMP) hydrolysing activity by sildenafil analogues that inhibit cellular cGMP efflux
  di: Subbotina, Anna, et al.
  Pubblicazione: (2017)
• Type II cyclic guanosine monophosphate-dependent protein kinase inhibits epidermal growth factor receptor activation in different cancer cell lines
  di: JIANG, LU, et al.
  Pubblicazione: (2015)
• Alterations in the Cerebellar (Phospho)Proteome of a Cyclic Guanosine Monophosphate (cGMP)-dependent Protein Kinase Knockout Mouse
  di: Corradini, Eleonora, et al.
  Pubblicazione: (2014)
• 2′,3′-cGMP exists in vivo and comprises a 2′,3′-cGMP-guanosine pathway
  di: Jackson, Edwin K., et al.
  Pubblicazione: (2019)
• Ergometric exercise testing and sensitivity of cyclic guanosine 3',5'-monophosphate (cGMP) in diagnosing asymptomatic left ventricular dysfunction.
  di: Jakob, G., et al.
  Pubblicazione: (1995)